Call Us
Home » Products » Elisa Test Kits » Hepatitis E Virus Elisa Kit

Hepatitis E Virus Elisa Kit

Hepatitis E Virus Elisa Kit
Hepatitis E Virus Elisa Kit
Send Inquiry
Product Code : 08
Brand Name : Bioneovan
  • Price Range
  • 1.00 - 400.00 USD ($)
  • FOB Port
  • China
  • Payment Terms
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Delivery Point (DP), Cash Advance (CA), Cash on Delivery (COD), Cash Against Delivery (CAD)
  • Supply Ability
  • 10000 Box/Boxes per Month 25 workdays Per Month
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India
Product Description
This Hepatitis E Virus Elisa Kit offered by us is an enzyme linked-immunosorbent assay for in vitro qualitative detection of total antibodies to hepatitis E virus in human serum or plasma. The Enzyme Immuno Assay (ELISA) is intended to be used as a qualitative determination of IgG antibodies to Hepatitis E infection. This kit is used for the screening of blood units and the follow-up of HEV-infected patients.

  • Complete range of ELISAs for separate or parallel determination of antibodies against HEV
  • Highest sensitivity and specificity for antibody detection
  • First-rate linearity with respect to the WHO standard
  • Ideal for differential diagnostics, blood donor screening and epidemiology
  • Fully automatable

This kit is an enzyme-linked immunosorbent assay for quantitative detection of Interferon Gamma (IFN-γ) that responds to in-vitro stimulation by Mycobacterium tuberculosis antigens in fresh human whole blood. It is intended for use as an aid in the diagnosis of tuberculosis (TB) infection.

Tuberculosis is a communicable disease caused by infection with M.tuberculosis (MTB)complex organisms (M. tuberculosis, M. bovis, M. africanum), which typically spread to new hosts via airborne droplet nuclei from patients with respiratory tuberculosis disease. It is one of the most important health threatening problems worldwide. The World Health Organization estimates that one third of the world’s population is infected with M.tuberculosis. Each person carrying latent TB infection (LTBI) has approximately a 10% chance of progressing to active disease. Interferon Gamma Release Assay (IGRA) measure a person’s immune reactivity to M.tuberculosis. T lymphocytes from most persons that have been infected with M.tuberculosis will release IFN-γ when mixed with special antigens derived from M.tuberculosis. IGRA is whole-blood test that can aid in diagnosing Mycobacterium tuberculosis infection, including both latent tuberculosis infection (LTBI) and tuberculosis (TB) disease.


Back to top
BIONEOVAN CO., LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.